Episurf Medical reports that more than 100 Episealer® patients have had their knee implants for more than three years, and more than 200 patients have had them for more than two years.
In 1Q19, the company announced that 500 patients had been treated with the Episealer knee. A significant number of those, especially among the first to be treated, are being monitored in clinical studies. Results reported to date show significant improvements in pain, symptoms and quality of life, as well as low revision rates.
Source: Episurf Medical
Episurf Medical reports that more than 100 Episealer® patients have had their knee implants for more than three years, and more than 200 patients have had them for more than two years.
In 1Q19, the company announced that 500 patients had been treated with the Episealer knee. A significant number of those, especially among the first to be...
Episurf Medical reports that more than 100 Episealer® patients have had their knee implants for more than three years, and more than 200 patients have had them for more than two years.
In 1Q19, the company announced that 500 patients had been treated with the Episealer knee. A significant number of those, especially among the first to be treated, are being monitored in clinical studies. Results reported to date show significant improvements in pain, symptoms and quality of life, as well as low revision rates.
Source: Episurf Medical
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





